Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — PSIX

Balance Sheet

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Cash & Equivalents	70.06	45.09	41.25	49.05	49.46	50.02	55.25	40.46	28.80	33.06	22.76	31.79	27.78	26.93	24.30	16.48	3.45	2.27	6.26	4.99
Accounts Receivable	80.18	73.69	90.45	87.97	82.10	81.61	68.96	77.49	64.26	49.29	66.98	71.42	78.20	83.08	89.89	82.73	86.80	71.25	65.11	54.55
Inventory	127.58	129.24	127.36	152.22	148.98	116.79	93.87	104.89	93.45	88.80	84.95	94.39	113.22	132.27	120.56	127.22	131.13	139.06	142.19	144.81
Total Current Assets	302.53	274.83	290.92	318.87	310.30	278.25	254.34	265.17	231.60	209.07	205.38	226.34	242.12	265.15	255.27	248.41	241.79	231.49	230.23	222.33
Property, Plant & Equipment	31.91	32.28	23.01	21.10	21.01	19.68	15.41	14.10	14.63	14.91	14.93	13.94	13.82	13.27	13.84	14.39	15.03	15.99	17.34	18.56
Goodwill	34.92	34.92	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84	29.84
Intangible Assets	1.33	1.61	1.24	1.53	1.84	2.15	2.45	2.82	3.18	3.55	3.91	4.35	4.79	5.22	5.66	6.19	6.71	7.24	7.78	8.42
Total Non-current Assets*	150.78	155.85	133.82	140.07	127.38	94.48	73.85	73.97	75.96	77.73	78.92	79.14	75.46	62.67	64.64	63.17	65.26	67.48	70.31	72.97
Total Assets	453.32	430.68	424.75	458.95	437.68	372.73	328.18	339.14	307.56	286.80	284.30	305.48	317.59	327.82	319.91	311.58	307.05	298.97	300.54	295.30
Accounts Payable	49.51	42.54	48.20	83.59	89.61	66.20	58.21	76.61	66.94	72.82	67.36	75.52	71.70	79.69	76.43	73.12	75.88	82.60	93.26	89.75
Short-term Debt	--	--	0.00	0.00	95.00	110.00	120.00	135.00	134.82	139.82	144.82	159.82	189.82	209.82	205.61	211.00	209.82	170.00	155.00	155.46
Total Current Liabilities	117.59	80.37	92.28	139.58	246.87	239.51	227.57	259.22	243.84	245.75	248.30	276.26	297.86	327.25	319.27	326.96	324.86	289.33	283.31	296.17
Long-term Debt	72.65	103.44	96.62	96.73	1.84	1.01	0.18	0.24	0.29	0.15	0.18	0.24	0.30	0.35	5.20	0.46	0.54	25.59	25.64	0.68
Total Non-current Liabilities*	132.66	164.53	153.86	156.91	55.17	48.88	35.37	37.81	38.95	37.83	39.92	41.53	39.85	27.15	31.02	24.39	25.20	54.06	59.25	33.63
Total Liabilities	250.25	244.91	246.14	296.49	302.03	288.39	262.93	297.03	282.80	283.58	288.22	317.79	337.71	354.40	350.29	351.34	350.06	343.39	342.56	329.81
Retained Earnings	46.64	29.78	22.48	6.40	(21.22)	(72.43)	(91.51)	(114.80)	(132.13)	(153.68)	(160.79)	(169.16)	(176.95)	(183.37)	(187.10)	(196.41)	(199.61)	(200.96)	(198.37)	(190.79)
Total Stockholder Equity	203.07	185.78	178.61	162.45	135.65	84.34	65.25	42.11	24.77	3.22	(3.92)	(12.30)	(20.12)	(26.58)	(30.37)	(39.76)	(43.01)	(44.42)	(42.02)	(34.51)

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	152.54	128.59	191.22	203.83	191.91	135.45	144.30	125.84	110.59	95.24	104.76	115.88	121.87	116.47	137.01	124.90	120.48	98.95	126.98	117.63
Cost of Revenue	111.18	99.17	149.41	155.12	137.82	95.15	101.13	89.42	75.40	69.48	77.22	87.98	94.91	93.00	107.59	100.79	102.16	82.23	117.31	106.29
Gross Profit	41.37	29.42	41.81	48.71	54.08	40.29	43.17	36.42	35.19	25.76	27.54	27.91	26.95	23.47	29.42	24.11	18.32	16.72	9.66	11.34
Research & Development	5.05	4.81	4.51	4.79	4.62	4.24	5.25	4.65	4.96	5.20	5.43	4.76	4.66	4.60	4.96	4.82	4.55	4.56	4.66	5.44
Selling, General & Admin	12.12	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Operating Expenses	17.45	18.03	17.57	20.35	21.60	15.66	17.98	15.97	9.84	15.09	15.20	15.79	15.65	14.95	15.51	16.89	15.08	16.49	15.31	17.03
Operating Income	23.92	11.39	24.24	28.36	32.48	24.63	25.19	20.45	25.34	10.66	12.33	12.11	11.31	8.52	13.91	7.22	3.24	0.23	(5.64)	(5.69)
Interest Expense	--	--	--	--	--	--	--	--	--	3.35	3.60	4.16	4.64	4.67	4.30	3.62	2.67	2.44	2.05	1.62
Pretax Income	22.47	9.73	22.68	26.74	31.08	22.87	22.84	17.61	22.44	7.32	8.74	7.95	6.66	3.86	9.61	3.61	0.57	(2.21)	(7.70)	(7.31)
Tax Provision	5.61	2.43	6.60	(0.88)	(20.14)	3.79	(0.45)	0.28	0.90	0.20	0.37	0.15	0.24	0.14	0.29	0.42	(0.79)	0.39	(0.12)	(0.13)
Net Income	16.86	7.30	16.08	27.62	51.21	19.08	23.29	17.34	21.54	7.12	8.37	7.80	6.42	3.72	9.32	3.19	1.36	(2.60)	(7.57)	(7.18)
Basic EPS	0.73	0.32	0.69	1.20	2.23	0.83	1.01	0.75	0.94	0.31	0.37	0.34	0.28	0.16	0.40	0.14	0.06	(0.11)	(0.34)	(0.31)
Diluted EPS	0.73	0.32	0.69	1.20	2.22	0.83	1.01	0.75	0.94	0.31	0.37	0.34	0.28	0.16	0.40	0.14	0.06	(0.11)	(0.34)	(0.31)

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	56.59	19.13	(4.62)	3.26	16.66	8.81	32.65	12.58	1.53	15.63	8.40	35.54	21.57	5.00	8.86	12.49	(12.82)	(17.38)	(22.38)	(24.86)
Capital Expenditures	0.85	1.89	3.01	1.53	2.04	3.40	2.60	0.43	0.71	0.82	2.36	1.42	0.64	0.61	0.36	0.48	0.39	0.12	(0.19)	0.97
Free Cash Flow*	55.75	17.24	(7.62)	1.73	14.63	5.41	30.05	12.15	0.82	14.82	6.04	34.12	20.93	4.39	8.50	12.00	(13.21)	(17.49)	(22.19)	(25.83)
Investing Cash Flow	(0.85)	(13.80)	(3.00)	(1.53)	(2.02)	(3.40)	(2.60)	(0.43)	(0.71)	(0.81)	(2.34)	(1.42)	(0.64)	(0.61)	(0.36)	(0.48)	(0.39)	(0.12)	0.20	(0.84)
Financing Cash Flow	(30.76)	(0.74)	(0.16)	(2.12)	(15.18)	(10.24)	(15.23)	(0.46)	(5.06)	(5.18)	(15.06)	(30.06)	(20.05)	(1.63)	(0.64)	1.14	14.68	13.19	23.83	25.32

← Scroll for more columns →

* Derived from reported values